Pharmaceutical News and Articles

Trump Says He'll Try to Rid U.S. of Daylight Saving Time

President-elect Donald Trump is calling for an end to daylight saving time, a practice he described as inconvenient and costly. The Republican Party will use it

Texas Sues NY Doctor for Prescribing Abortion Pill by Telehealth

A New York doctor has been sued by the state of Texas for prescribing abortion pills via telehealth to a Dallas woman. In a news release announcing the filing o

Patient in Louisiana Hospitalized With First Bird Flu Case in That State

Louisiana has reported what appears to be the state s first case of bird flu. In a health alert issued Friday, state officials said the case involves a resident

Tolebrutinib Designated Breakthrough Therapy by the FDA for Non-Relapsing Secondary Progressive Multiple Sclerosis

Paris, December 13, 2024. The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of adults wit

FDA Approves Unloxcyt (cosibelimab-ipdl) for the Treatment of Cutaneous Squamous Cell Carcinoma

FDA Approves Crenessity (crinecerfont) for the Treatment of Children and Adults with Classic Congenital Adrenal Hyperplasia

Wintertime Is Prime Time for Head Lice: What Parents Need to Know

Head lice can be a wintertime headache for families and schools, but simple precautions can stop the spread of these pesky parasites.Every year, 6 million to 12

Combo Treatment With Xalnesiran Shows Promise in Patients With Hep B

For patients with chronic hepatitis B virus (HBV) infection with virologic suppression with nucleoside or nucleotide analog (NA) therapy, xalnesiran plus an imm

Breast Reconstruction Rates Stable After Increase From 2005 to 2012

Breast reconstruction (BR) rates increased from 2005 to 2012, then stabilized from 2013 to 2017, according to a study published online in the December issue of

SABCS: Adding Camrelizumab to Neoadjuvant Chemo Beneficial in TNBC

The addition of camrelizumab to neoadjuvant chemotherapy improves pathological complete response for patients with early or locally advanced triple-negative bre